Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine to volunteers in COVID prevention study

This month we have been busy vaccinating volunteers in North Manchester, Preston and North London for a new COVID prevention study. It has been an exciting time as we were the world’s first clinical trial site to administer the vaccine to volunteers in this study. The first participant to be vaccinated at our Rochdale clinic …

Read more

Clinical trial specialist Panthera Biopartners has appointed corporate financier Christopher Steed as a non-executive director to continue its expansion both in the UK and overseas

Independent clinical trial site management organisation (SMO), Panthera Biopartners, has appointed M&A and fundraisings adviser Chris Steed as a non-executive director. Chris has over 25 years’ experience as a corporate financier, working at Arthur Andersen, Deloitte and for the past 17 years as Founder and Managing Partner of Argyll Partners. Chris has acted as lead advisor …

Read more

Panthera adapts for COVID-19 virus – Letter from Stuart Young, CEO

As we all continue to adapt to the COVID-19 pandemic, we at Panthera are closely monitoring this rapidly evolving situation as well as remaining vigilant to support our patients and the NHS in any way we can. Panthera sites will remain open for business with significant additional precautions to prevent transmission of the COVID-19 virus. …

Read more